Biotechnology Stocks Advancing On Cephalon Takeover Offer – RTT News
By Dr. Matthew Watson
 Sydney Morning Herald | Biotechnology Stocks Advancing On Cephalon Takeover Offer RTT News (RTTNews) - Biotechnology stocks have shown a strong upward move on Wednesday, with Cephalon (CEPH) leading the way higher after receiving a hostile takeover offer from Valeant Pharmaceuticals (VRX). The strength among biotech stocks is reflected by ... Analyst: Valeant might pay more than $5.7B for CephalonBizjournals.com (blog) Former OC Drug Maker Valeant Makes Waves With Hostile Bid for CephalonOrange County Business Journal |
Uncategorized
Comments Off on Biotechnology Stocks Advancing On Cephalon Takeover Offer – RTT News |
April 3rd, 2011
This author published 5852 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research